|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Caladrius Biosciences (NASDAQ: CLBS) through any online brokerage.
The latest price target for Caladrius Biosciences (NASDAQ: CLBS) was reported by Brookline Capital on March 3, 2021. The analyst firm set a price target for 10.00 expecting CLBS to rise to within 12 months (a possible 651.88% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Caladrius Biosciences (NASDAQ: CLBS) is $1.33 last updated Fri Jul 30 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Caladrius Biosciences.
There is no upcoming split for Caladrius Biosciences.
Caladrius Biosciences is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.